To overcome these problems, we have used a cell-penetrating peptide called HK2pep that displaces HK2 from MAMs without targeting its catalytic activity, with the aim of eliciting tumor cell apoptosis while avoiding off-target effects caused by metabolic disruptions. This evidence concerns the gene HK2 and neoplasm.